Hans van Dam

7.3k total citations · 1 hit paper
77 papers, 5.9k citations indexed

About

Hans van Dam is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Hans van Dam has authored 77 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 25 papers in Oncology and 19 papers in Genetics. Recurrent topics in Hans van Dam's work include TGF-β signaling in diseases (17 papers), Ubiquitin and proteasome pathways (15 papers) and Virus-based gene therapy research (14 papers). Hans van Dam is often cited by papers focused on TGF-β signaling in diseases (17 papers), Ubiquitin and proteasome pathways (15 papers) and Virus-based gene therapy research (14 papers). Hans van Dam collaborates with scholars based in Netherlands, China and United States. Hans van Dam's co-authors include Peter ten Dijke, Marc Castellazzi, Peter Angel, Long Zhang, Peter Herrlich, Fangfang Zhou, Ingrid Herr, Feng Xie, Dagmar Wilhelm and Anja Steffen and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Hans van Dam

75 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents.

1995 551 citations Hans van Dam, Dagmar Wilhelm et al. profile →

Peers

Countries citing papers authored by Hans van Dam

Since Specialization

Citations

This map shows the geographic impact of Hans van Dam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans van Dam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans van Dam more than expected).

Fields of papers citing papers by Hans van Dam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans van Dam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans van Dam. The network helps show where Hans van Dam may publish in the future.

Co-authorship network of co-authors of Hans van Dam

This figure shows the co-authorship network connecting the top 25 collaborators of Hans van Dam. A scholar is included among the top collaborators of Hans van Dam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans van Dam. Hans van Dam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Pro‐Fluorescent Ubiquitin‐Based Probe to Monitor Cysteine‐Based E3 Ligase Activity 2023 ·Angewandte Chemie International Edition ·(unknown), T. M. Vishwanatha, Daniel Horn‐Ghetko, (unknown), (unknown), (unknown), Mohit Misra, Ivan Đikić, Paul P. Geurink, Hans van Dam, Brenda A. Schulman, Monique P. C. Mulder	2
2	Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2 2023 ·ACS Chemical Biology ·Gan Jin, J. de Vries, Jimmy J.L.L. Akkermans, Yassene Mohammed, (unknown), Arnoud H. de Ru, Robbert Q. Kim, David A. Vargas, (unknown), Rudi Fasan, Peter A. van Veelen, Jacques Neefjes, Hans van Dam, Huib Ovaa, Ayşegül Sapmaz, Paul P. Geurink	5
3	Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling 2022 ·Nature Communications ·Feng Xie, Xiaoxue Zhou, Peng Su, Heyu Li, Yifei Tu, (unknown), Chen Pan, Wei Xiang, Min Zheng, Ke Jin, Liyan Miao, Chao Wang, Xuli Meng, Hans van Dam, Peter ten Dijke, Long Zhang, Fangfang Zhou	102
4	OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ 2018 ·Molecular Cell ·Zhengkui Zhang, (unknown), Shuai Wang, Li Shao, Ke Jin, Fang Li, Bajin Wei, Wei Ding, Peifen Fu, Hans van Dam, Aijun Wang, Jin Jin, Chen Ding, Bing Yang, Min Zheng, Xin‐Hua Feng, Kun‐Liang Guan, Long Zhang	141
5	FAF1 Regulates Antiviral Immunity by Inhibiting MAVS but Is Antagonized by Phosphorylation upon Viral Infection 2018 ·Cell Host & Microbe ·Tong Dai, Liming Wu, Shuai Wang, Jing Wang, Feng Xie, Zhengkui Zhang, (unknown), Jingxian Li, Pengfei Fang, Fang Li, Ke Jin, Jianfeng Dai, Bing Yang, Fangfang Zhou, Hans van Dam, Dachuan Cai, Huizhe Huang, Long Zhang	42
6	Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer? 2018 ·Oncogene ·(unknown), D.A. Baker, Peter ten Dijke, Hans van Dam	138
7	Regulation of the TGF-β pathway by deubiquitinases in cancer 2016 ·The International Journal of Biochemistry & Cell Biology ·Sijia Liu, (unknown), Hans van Dam, Peter ten Dijke	29
8	UBE2O negatively regulates TRAF6-mediated NF-κB activation by inhibiting TRAF6 polyubiquitination 2013 ·Cell Research ·Xiaofei Zhang, Juan Zhang, Long Zhang, Hans van Dam, Peter ten Dijke	76
9	Ubiquitin-specific Protease 4 Mitigates Toll-like/Interleukin-1 Receptor Signaling and Regulates Innate Immune Activation 2012 ·Journal of Biological Chemistry ·Fangfang Zhou, Xiaofei Zhang, Hans van Dam, Peter ten Dijke, Huizhe Huang, Long Zhang	78
10	RNF12 Controls Embryonic Stem Cell Fate and Morphogenesis in Zebrafish Embryos by Targeting Smad7 for Degradation 2012 ·Molecular Cell ·Long Zhang, Huizhe Huang, Fangfang Zhou, Joost Schimmel, Cristina Gontan, Tingting Zhang, Tahsin Stefan Barakat, Kelly-Ann Sheppard, Craig Mickanin, Jeff Porter, Alfred C.O. Vertegaal, Hans van Dam, Joost Gribnau, Chuang Lu, Peter ten Dijke	4
11	GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb 2011 ·Molecular Biology of the Cell ·Fangfang Zhou, Long Zhang, Theo van Laar, Hans van Dam, Peter ten Dijke	52
12	BMP-7 inhibits TGF-β-induced invasion of breast cancer cells through inhibition of integrin β3 expression 2011 ·Cellular Oncology ·Hildegonda P. H. Naber, Eliza Wiercinska, Evangelia Pardali, Theo van Laar, (unknown), Anders Sundqvist, Hans van Dam, Geertje van der Horst, Gabri van der Pluijm, Bertrand Heckmann, Erik H.J. Danen, Peter ten Dijke	49
13	In Situ Proximity Ligation Detection of c-Jun/AP-1 Dimers Reveals Increased Levels of c-Jun/Fra1 Complexes in Aggressive Breast Cancer Cell Lines in Vitro and in Vivo 2010 ·Molecular & Cellular Proteomics ·(unknown), Evangelia Pardali, Peter ten Dijke, Hans van Dam	22
14	Site-Specific Identification of SUMO-2 Targets in Cells Reveals an Inverted SUMOylation Motif and a Hydrophobic Cluster SUMOylation Motif 2010 ·Molecular Cell ·Ivan Matić, Joost Schimmel, Ivo A. Hendriks, (unknown), Frans Van De Rijke, Hans van Dam, Florian Gnad, Matthias Mann, Alfred C.O. Vertegaal	260
15	ATF3 and Fra1 have opposite functions in JNK- and ERK-dependent DNA damage responses 2008 ·DNA repair ·Mohamed Hamdi, Herman E. Popeijus, Françoise Carlotti, Josephine M. Janssen, (unknown), Paulien Cornelissen‐Steijger, Bob van de Water, Rob C. Hoeben, Koichi Matsuo, Hans van Dam	34
16	Aberrant Polycystin-1 Expression Results in Modification of Activator Protein-1 Activity, whereas Wnt Signaling Remains Unaffected 2004 ·Journal of Biological Chemistry ·(unknown), (unknown), Gerwin Huls, Marc van de Wetering, Mahmoud Loghman‐Adham, Albert Ong, James P. Calvet, Hans Clevers, Martijn H. Breuning, Hans van Dam, Dorien J.M. Peters	35
17	Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis 2001 ·Oncogene ·Hans van Dam, Marc Castellazzi	375
18	Both ATF-2 and c-Jun are Phosphorylated by Stress-Activated Protein Kinases in Response to UV Irradiation 1995 ·Immunobiology ·Dagmar Wilhelm, Hans van Dam, Ingrid Herr, Bernd Baumann, Peter Herrlich, Peter Angel	36
19	Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiation 1994 ·Carcinogenesis ·Ingrid Herr, Hans van Dam, Peter Angel	89
20	Differential Effects of the Adenovirus E1A Oncogene on Members of the AP-1 Transcription Factor Family 1990 ·Molecular and Cellular Biology ·Hans van Dam, Rienk Offringa, Ingeborg Meijer, Bernd Stein, Alida M.M. Smits, Peter Herrlich, Johannes L. Bos, Alex J. van der Eb	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact